TrialFuture oncology (London, England)2024

Health-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial.

Alessandra Tedeschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.